Patent · US Expired

Single morphic forms of metalloproteinase inhibitors

US6277827A · kind A · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 22, 1999
Grant dateAug 21, 2001
Priority date—
Expiry dateOct 22, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A single morphic form of a compound selected from 2S-[4-(2,5-dioxopyrrolidin-1-yl)-2S-mercaptobutyrylamino]-4-methylpentanoi c acid (2,2-dimethyl-1S-methylcarbamoylpropyl)amide and 2S-[2S-mercapto-4-(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)butyrylamino ]-4-methylpentanoic acid (2,2-dimethyl-1S-methylcarbamoylpropyl)amide, isolable as such.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.